Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Plos One|September 20, 2017
The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injuryJochen Dutzmann, Robert-Jonathan Musmann, Marco Haertlé, et al.
Thrombosis and Haemostasis|June 12, 2015
Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injuryJan-Marcus Daniel, Fabian Reich, Jochen Dutzmann, et al.
Cardiovascular Research|November 1, 2017
Sonic hedgehog-dependent activation of adventitial fibroblasts promotes neointima formationJochen Dutzmann, Alexander Koch, Simona Weisheit, et al.
Blood|October 31, 2008
A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cellsAya Shibamiya, Karin Hersemeyer, Thomas Schmidt Wöll, et al.
The Journal of Experimental Medicine|December 6, 2006
The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formationDaniel Sedding, Jan-Marcus Daniel, Lars Muhl, et al.
Plos One|March 28, 2013
Role of the phosphatase PTEN in early vascular remodelingDaniel G Sedding, Rebecca Widmer-Teske, Andreas Mueller, et al.
Journal of Clinical Pathology|February 13, 2014
Comprehensive analysis of clinico-pathological data reveals heterogeneous relations between atherosclerosis and cancerJan Budczies, Moritz von Winterfeld, Frederick Klauschen, et al.
Frontiers in Cardiovascular Medicine|August 26, 2022
Empagliflozin prevents neointima formation by impairing smooth muscle cell proliferation and accelerating endothelial regenerationJochen Dutzmann, Lena Marie Bode, Katrin Kalies, et al.
Cardiovascular Research|July 15, 2014
Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injuryJan-Marcus Daniel, Daniela Penzkofer, Rebecca Teske, et al.
Pageof 3